Antenatal screening by culture of GBS (Streptococcus agalactiae) has reduced perinatal infections. However, its performance associated with a potential change in carriage makes intrapartum antibiotic prophylaxis sometimes risky. 61% of infected infants were born to culture-negative mothers at 8 months.
Accurately and promptly screen parturient on admission and administer antibiotics appropriately.
Intrapartum screening for vaginal or rectal GBS with BIOSYNEX AMPLIFLASH® GBS allows the appropriate administration of antibiotic prophylaxis to positive parturient.